Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas.
Financial Results:
Unichem Laboratories Ltd reported Revenues for Q2FY24 of ₹416.00 Crores up from ₹329.00 Crore year on year, a rise of 26.44%.
Total Expenses for Q2FY24 of ₹443.00 Crores up from ₹380.00 Crores year on year, a rise of 16.58%.
Consolidated Net Profit of -₹24.00 Crores from -₹71.00 Crores in the same quarter of the previous year.
The Earnings per Share is -₹3.48, from -₹10.04 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.